These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11306078)

  • 21. Aldose reductase does catalyse the reduction of glyceraldehyde through a stoichiometric oxidation of NADPH.
    Del Corso A; Costantino L; Rastelli G; Buono F; Mura U
    Exp Eye Res; 2000 Nov; 71(5):515-21. PubMed ID: 11040087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
    Steuber H; Heine A; Podjarny A; Klebe G
    J Mol Biol; 2008 Jun; 379(5):991-1016. PubMed ID: 18495158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
    Mohd Siddique MU; Thakur A; Shilkar D; Yasmin S; Halakova D; Kovacikova L; Prnova MS; Stefek M; Acevedo O; Dasararaju G; Devadasan V; Mondal SK; Jayaprakash V
    Eur J Med Chem; 2021 Nov; 223():113630. PubMed ID: 34175538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiological thiols as promoters of glutathione oxidation and modifying agents in protein S-thiolation.
    Del Corso A; Vilardo PG; Cappiello M; Cecconi I; Dal Monte M; Barsacchi D; Mura U
    Arch Biochem Biophys; 2002 Jan; 397(2):392-8. PubMed ID: 11795899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and aldose reductase inhibitory activity of benzoyl-amino acid derivatives.
    Benvenuti S; Severi F; Costantino L; Vampa G; Melegari M
    Farmaco; 1998 Jun; 53(6):439-42. PubMed ID: 9764478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of glutathione-modified aldose reductase in oxidatively stressed bovine lens.
    Cappiello M; Vilardo PG; Cecconi I; Leverenz V; Giblin FJ; Del Corso A; Mura U
    Biochem Biophys Res Commun; 1995 Feb; 207(2):775-82. PubMed ID: 7864872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interconversion pathways of aldose reductase induced by thiol compounds.
    Del Corso A; Vilardo PG; Barsotti C; Cappiello M; Cecconi I; Dal Monte M; Marini I; Banditelli S; Mura U
    Adv Exp Med Biol; 1999; 463():453-8. PubMed ID: 10352718
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase.
    Srivastava S; Chandra A; Bhatnagar A; Srivastava SK; Ansari NH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):741-6. PubMed ID: 8554593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives.
    Maccari R; Ottanà R; Ciurleo R; Rakowitz D; Matuszczak B; Laggner C; Langer T
    Bioorg Med Chem; 2008 Jun; 16(11):5840-52. PubMed ID: 18492610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.
    Carbone V; Giglio M; Chung R; Huyton T; Adams J; Maccari R; Ottana R; Hara A; El-Kabbani O
    Eur J Med Chem; 2010 Mar; 45(3):1140-5. PubMed ID: 20036445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors.
    Kumar H; Shah A; Sobhia ME
    J Mol Model; 2012 May; 18(5):1791-9. PubMed ID: 21833829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
    Carper DA; Hohman TC; Old SE
    Biochim Biophys Acta; 1995 Jan; 1246(1):67-73. PubMed ID: 7811733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of 1-benzopyran-4-one derivatives to aldose reductase: a free energy perturbation study.
    Rastelli G; Costantino L; Gamberini MC; Del Corso A; Mura U; Petrash JM; Ferrari AM; Pacchioni S
    Bioorg Med Chem; 2002 May; 10(5):1427-36. PubMed ID: 11886805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-(Aroyl)-N-(arylmethyloxy)-α-alanines: Selective inhibitors of aldose reductase.
    Nencetti S; La Motta C; Rossello A; Sartini S; Nuti E; Ciccone L; Orlandini E
    Bioorg Med Chem; 2017 Jun; 25(12):3068-3076. PubMed ID: 28392277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the glutathione binding site of aldose reductase.
    Ramana KV; Dixit BL; Srivastava S; Bhatnagar A; Balendiran GK; Watowich SJ; Petrash JM; Srivastava SK
    Chem Biol Interact; 2001 Jan; 130-132(1-3):537-48. PubMed ID: 11306073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of C7 modifications on benzothiadiazine-1,1-dioxide derivatives on their inhibitory activity and selectivity toward aldose reductase.
    Zhang S; Chen X; Parveen S; Hussain S; Yang Y; Jing C; Zhu C
    ChemMedChem; 2013 Apr; 8(4):603-13. PubMed ID: 23136050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
    Celestina SK; Sundaram K; Ravi S
    Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors.
    Pau A; Asproni B; Murineddu G; Boatto G; Grella GE; Rakowitz D; Costantino L; Pinna GA
    Med Chem; 2006 Jan; 2(1):39-45. PubMed ID: 16787354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications.
    Kumar M; Choudhary S; Singh PK; Silakari O
    Future Med Chem; 2020 Jul; 12(14):1327-1358. PubMed ID: 32602375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of aldose reductase by (2,6-dimethylphenylsulphonyl)nitromethane: possible implications for the nature of an inhibitor binding site and a cause of biphasic kinetics.
    Ward WH; Cook PN; Mirrlees DJ; Brittain DR; Preston J; Carey F; Tuffin DP; Howe R
    Adv Exp Med Biol; 1993; 328():301-11. PubMed ID: 8493907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.